Learn more

SYNTEX PHARMA LTD

Overview
  • Total Patents
    46
About

SYNTEX PHARMA LTD has a total of 46 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are LEAD DISCOVERY CENTER GMBH, ANGIBAUD PATRICK RENE and YING WEIWEN.

Patent filings per year

Chart showing SYNTEX PHARMA LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Pascal Jean-Claude 24
#2 Lee Chi-Ho 21
#3 Pinhas Henri 19
#4 Alps Brian J 18
#5 Whiting Roger L 18
#6 Mccort Gary 12
#7 Beranger Serge 11
#8 Blondet Dominique 9
#9 Pascal Jean C 7
#10 Gellibert Francoise 7

Latest patents

Publication Filing date Title
US5428037A Heterocyclic derivatives in the treatment of Ischaemia and related diseases
US5296609A Process for the preparation of 1,2,4-substituted imidazoles and related aminoalkylimidazole derivatives
US5252736A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US5091428A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US5063220A Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
PH27405A Process for the preparation of substituted imidazolyl-alkyl-piperazine and diazepine derivatives
US5010075A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4935417A Sustituted imidazolyl-alkyl-piperazine and -diazepine derivatives for treating cerebrovascular disease
US5043447A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4973591A Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US4829065A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives